Pharmaceutical composition for treating duck virus hepatitis and preparation method thereof

A technology of duck viral hepatitis and composition, which is applied in the field of Chinese veterinary medicine, can solve the problems of limited drug varieties, many adverse reactions, and long treatment courses, and achieve the effects of improving the body's immunity, low cost and no drug residue

Inactive Publication Date: 2015-01-07
SHANDONG NEW HOPE LIUHE GROUP
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, Western medicine has a single regimen for duck viral hepatitis, limited drug varieties, long

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating duck virus hepatitis and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0062] Example 1 Pharmaceutical composition 1

[0063] 20 parts by weight of puffball, 25 parts by weight of mulberry leaves, 30 parts by weight of honeysuckle, 15 parts by weight of Cimicifuga, 20 parts by weight of Bupleurum, 15 parts by weight of Caoguo, 18 parts by weight of Artemisia annua, 7 parts by weight of Changshan, 28 parts by weight of bean rolls 15 parts by weight of raw land, 16 parts by weight of red peony root, 14 parts by weight of Ophiopogon japonicus, 16 parts by weight of Imperata rhizome, 15 parts by weight of arborvitae leaves, 18 parts by weight of Scrophulariaceae, 15 parts by weight of comfrey, 20 parts by weight of forsythia, 8 parts by weight of Arrowhead Mushroom, 18 parts by weight of Ishimi, 16 parts by weight of Loulu, 18 parts by weight of Four Seasons Green, 18 parts by weight of black berry, 6 parts by weight of saxifrage, 15 parts by weight of purslane, Pteris vulgaris 16 parts by weight and 20 parts by weight of licorice.

[0064] Its prep...

Embodiment 2

[0067] Example 2 Pharmaceutical composition 2

[0068] 20 parts by weight of puffball, 25 parts by weight of mulberry leaves, 30 parts by weight of honeysuckle, 15 parts by weight of Cimicifuga, 20 parts by weight of Bupleurum, 15 parts by weight of Caoguo, 18 parts by weight of Artemisia annua, 7 parts by weight of Changshan, 28 parts by weight of bean rolls 15 parts by weight of raw land, 16 parts by weight of red peony root, 14 parts by weight of Ophiopogon japonicus, 16 parts by weight of Imperata rhizome, 15 parts by weight of arborvitae leaves, 18 parts by weight of Scrophulariaceae, 15 parts by weight of comfrey, 20 parts by weight of forsythia, 8 parts by weight of Arrowhead Mushroom, 18 parts by weight of Ishimi, 16 parts by weight of Loulu, 18 parts by weight of Four Seasons Green, 18 parts by weight of black berry, 6 parts by weight of saxifrage, 15 parts by weight of purslane, Pteris vulgaris 16 parts by weight, 20 parts by weight of licorice, 15 parts by weight of...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a pharmaceutical composition for treating duck virus hepatitis and a preparation method thereof. The pharmaceutical composition comprises the following raw material medicines: puffball, folium mori, honeysuckle, Rhizoma Cimicifugae, radix bupleuri, Amomum tsao-ko, sweet wormwood, antifebrile dichroa, black soybeans, root of rehmannia, root of common peony, Radix Ophiopogonis, lalang grass rhizome, Cacumen biotae, radix scrophulariae, lithospermum, fructus forsythiae, edible tulip, salvia chinensis, Uniflower Swisscentaury Root, leaf of purpleflower holly, Japanese Cayratia Herb, Saxifraga stolonifera, purslane, phoenix-tail fern and liquorice. The pharmaceutical composition has the beneficial effects that the pharmaceutical composition disclosed by the invention has the main effects of clearing away heat and toxic materials and activating blood circulation and cooling blood as well as auxiliary effects of tonifying qi and strengthening exterior, the body immunity of ill ducks can be improved, the pharmaceutical composition is good in curative effect and low in cost and price and does not have drug tolerance or drug residue, and the state of the illness can be effectively controlled.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese veterinary medicine, in particular to a pharmaceutical composition for treating duck viral hepatitis and a preparation method thereof. Background technique [0002] Duck viral hepatitis, referred to as duck hepatitis for short, is an acute severe infectious disease of ducklings caused by duck viral hepatitis virus, characterized by hemorrhagic inflammation in the liver. The disease was discovered for the first time in the United States in 1945 and named as type I duck viral hepatitis. In 1965, duck viral hepatitis type II was discovered in the United Kingdom. In 1969, duck viral hepatitis type III was discovered in the United States. At present, type I is distributed worldwide, and it has been reported that variant strains of type I duck hepatitis virus have been found in India, Egypt and the United States. Type II and Type III duck viral hepatitis were confined to the United Kingdom ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/9064A61K9/16A61K9/08A61P1/16A61P31/14
CPCA61K36/06A61K9/0019A61K9/08A61K9/1652A61K35/34A61K36/11A61K36/14A61K36/17A61K36/185A61K36/19A61K36/233A61K36/27A61K36/28A61K36/282A61K36/30A61K36/355A61K36/48A61K36/481A61K36/484A61K36/53A61K36/56A61K36/605A61K36/634A61K36/65A61K36/704A61K36/71A61K36/80A61K36/804A61K36/808A61K36/87A61K36/8968A61K36/898A61K36/899A61K36/9064A61K2236/15A61K2236/331A61K2236/51A61K2300/00
Inventor 庄志伟秦立廷燕磊
Owner SHANDONG NEW HOPE LIUHE GROUP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap